Adverum Biotechnologies, Inc. (ADVM)

USD 4.81

(-8.03%)

Annual Income Statements

(In USD)
Breakdown 2023 2022 2021 2020 2019 2018
Revenue 3.6 Million - 7.5 Million - 250 Thousand 1.61 Million
Cost of Revenue 5.64 Million 6.52 Million 4.64 Million 4.15 Million - -
Gross Profit -2.04 Million -6.52 Million 2.85 Million -4.15 Million 250 Thousand 1.61 Million
Operating Expenses 127.59 Million 157.13 Million 153.62 Million 117.95 Million 68.79 Million 74.69 Million
Selling, General and Administrative Expenses 49.91 Million 57.85 Million 64.44 Million 44.64 Million 28.37 Million 24.56 Million
Research and Development Expenses 77.67 Million 99.27 Million 89.18 Million 73.3 Million 40.41 Million 50.13 Million
Other Expenses - 2.67 Million 582 Thousand 1.55 Million 4.05 Million 4.2 Million
Cost and Expenses 127.59 Million 157.13 Million 153.62 Million 117.95 Million 68.79 Million 74.69 Million
Operating Income -123.79 Million -157.13 Million -146.12 Million -117.95 Million -68.54 Million -78.08 Million
Interest Expense - - - - - -
Income Tax Expense -1.07 Million 74 Thousand 4.4 Million 1.11 Million 1.4 Million -1.25 Million
Earnings before Tax -118.24 Million -154.46 Million -145.54 Million -116.39 Million -64.48 Million -73.87 Million
Net Income -117.16 Million -154.53 Million -145.54 Million -117.5 Million -64.48 Million -72.62 Million
Earnings Per Share Basic -11.62 -15.57 -14.85 -13.80 -10.06 -1.18
Earnings Per Share Diluted -11.62 -15.57 -14.85 -13.80 -10.06 -1.18
Weighted Average Shares Outstanding 10.08 Million 9.92 Million 9.8 Million 8.51 Million 6.41 Million 61.37 Million
Weighted Average Shares Outstanding (Diluted) 10.08 Million 9.92 Million 9.8 Million 8.51 Million 6.41 Million 61.37 Million
Gross Margin -0.57 - 0.38 - 1.00 1.00
EBIT Margin -31.28 - -18.86 - -267.89 -41.15
Profit Margin -32.55 - -19.41 - -257.94 -45.05
EBITDA -112.59 Million -147.93 Million -140.89 Million -112.23 Million -62.91 Million -72.12 Million
Earnings Before Tax Margin -34.39 - -19.48 - -274.18 -48.44

Income Statement Charts